Research Explorer

Uw browser ondersteunt geen JavaScript of JavaScript is niet ingeschakeld. Zonder JavaScript kan sommige functionaliteit van deze webapplicatie uitgeschakeld zijn of foutmeldingen veroorzaken. Raadpleeg om JavaScript in te schakelen de handleiding van uw browser of contacteer uw systeembeheerder.

Onderzoeker

Jan Vanwelkenhuyzen

Publicaties & datasets

Prijzen & Erkenningen

12 Resultaten

2025

Prognostic value of the circulating tumor DNA fraction in metastatic castration-resistant prostate cancer : results from the ProBio platform trial

Alessio CrippaBram De LaereAndrea DiscacciatiBerit LarssonMaria PerssonSusanne JohanssonSanne D'hondtMarie Hjälm-ErikssonLinn PetterssonGunilla Enblad et al.

A1 Artikel in een tijdschrift in EUROPEAN UROLOGY ONCOLOGY

2024

Androgen receptor pathway inhibitors and taxanes in metastatic prostate cancer : an outcome-adaptive randomized platform trial

Bram De LaereAlessio CrippaAndrea DiscacciatiBerit LarssonMaria PerssonSusanne JohanssonSanne D'hondtRebecka BergstromVenkatesh ChellappaMarkus Mayrhofer et al.

A1 Artikel in een tijdschrift in NATURE MEDICINE

Androgen receptor pathway inhibitors and taxanes in metastatic prostate cancer : an outcome-adaptive randomized platform trial (vol 30, pg 3291, 2024)

Bram De LaereAlessio CrippaAndrea DiscacciatiBerit LarssonMaria PerssonSusanne JohanssonSanne D'hondtRebecka BergstromVenkatesh ChellappaMarkus Mayrhofer et al.

From mutations to splice variants : identifying liquid biopsy derived biomarkers in metastatic prostate cancer

Jan VanwelkenhuyzenPiet OstBram De LaereKatleen De Preter

2023

AR and PI3K genomic profiling of cell-free DNA can identify poor responders to Lutetium-177-PSMA among patients with metastatic castration-resistant prostate cancer

Jan VanwelkenhuyzenEva Van BosSiska Van BruwaeneKarl LesageAlex MaesSezgin ÜstmertFilip LaventLaurence BeelsHenrik GrönbergPiet Ost et al.

A1 Artikel in een tijdschrift in EUROPEAN UROLOGY OPEN SCIENCE

2022

Development of an androgen receptor (AR) splice variant targeting, cell-free RNA and treatment-predictive biomarker assay for men with metastatic castration-resistant prostate cancer (mCRPC)

Jan Vanwelkenhuyzen

Toward methodology for comprehensive androgen receptor splice variant profiling in cell-free RNA from patients with metastatic prostate cancer

Jan VanwelkenhuyzenPieter-Jan van DamKatleen De PreterJohan LindbergPiet OstBram De Laere

Towards the discovery of prognostic and predictive biomarkers in CHEERS, a radioimmunotherapy phase II trial

Jan VanwelkenhuyzenMathieu SpaasKim Van der EeckenVibeke KruseSylvie RotteyLieve BrochezJohan LindbergKatleen De PreterBram De LaerePiet Ost

2021

Multifocality in prostate cancer : implications for PAM50 subtyping using an index lesion-only approach

Kim Van der EeckenMaarten LarmuseauJan VanwelkenhuyzenNicolaas LumenKathleen MarchalJo Van DorpePiet OstBram De LaereSofie Verbeke

Tissue- and blood-derived genomic biomarkers for metastatic hormone-sensitive prostate cancer : a systematic review

Kim Van der EeckenJan VanwelkenhuyzenMatthew P. DeekPhuoc T. TranEvan WarnerAlexander W. WyattEdmond M. KwanSofie VerbekeJo Van DorpeValerie Fonteyne et al.

A1 Artikel in een tijdschrift in EUROPEAN UROLOGY ONCOLOGY

2020

Inferring the genomic landscape of lymph-node positive high-risk prostate cancer

Jan VanwelkenhuyzenKim Van der EeckenBram De LaereSimon SundlingRebecka BergströmJohan LindbergKatleen De PreterHenrik GrönbergPiet Ost

Tracking the origins of metastatic seeding in de novo metastatic prostate cancer

Kim Van der EeckenEvan WarnerNicolaas LumenMatti AnnalaAndrew MurthaElena SchönlauNicolette FonsecaCameron HerbertsJan VanwelkenhuyzenWesley Verla et al.